A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 33,418 shares of TMO stock, worth $17.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
33,418
Previous 30,509 9.53%
Holding current value
$17.1 Million
Previous $16.9 Million 22.52%
% of portfolio
0.07%
Previous 0.06%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$531.86 - $624.21 $1.55 Million - $1.82 Million
2,909 Added 9.53%
33,418 $20.7 Million
Q2 2024

Jul 26, 2024

SELL
$541.52 - $599.02 $1.81 Million - $2 Million
-3,346 Reduced 9.88%
30,509 $16.9 Million
Q1 2024

Apr 24, 2024

SELL
$528.82 - $599.43 $557,376 - $631,799
-1,054 Reduced 3.02%
33,855 $19.7 Million
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $3.55 Million - $4.38 Million
-8,219 Reduced 19.06%
34,909 $18.5 Million
Q3 2023

Oct 24, 2023

BUY
$498.29 - $574.41 $3.02 Million - $3.48 Million
6,055 Added 16.33%
43,128 $21.8 Million
Q2 2023

Jul 13, 2023

SELL
$508.46 - $591.13 $235,416 - $273,693
-463 Reduced 1.23%
37,073 $19.3 Million
Q1 2023

May 11, 2023

SELL
$535.0 - $604.82 $508,785 - $575,183
-951 Reduced 2.47%
37,536 $21.6 Million
Q4 2022

Feb 08, 2023

SELL
$484.71 - $571.37 $1.6 Million - $1.89 Million
-3,310 Reduced 7.92%
38,487 $21.2 Million
Q3 2022

Oct 17, 2022

BUY
$507.19 - $604.49 $608,628 - $725,388
1,200 Added 2.96%
41,797 $21.2 Million
Q2 2022

Jul 13, 2022

SELL
$500.9 - $612.21 $443,296 - $541,805
-885 Reduced 2.13%
40,597 $22.1 Million
Q1 2022

May 12, 2022

SELL
$524.0 - $644.92 $427,584 - $526,254
-816 Reduced 1.93%
41,482 $24.5 Million
Q4 2021

Feb 03, 2022

BUY
$569.0 - $667.24 $3.2 Million - $3.75 Million
5,617 Added 15.31%
42,298 $28.2 Million
Q3 2021

Nov 02, 2021

SELL
$509.53 - $609.78 $2.96 Million - $3.55 Million
-5,819 Reduced 13.69%
36,681 $21 Million
Q2 2021

Aug 10, 2021

SELL
$441.0 - $508.24 $1.02 Million - $1.18 Million
-2,316 Reduced 5.17%
42,500 $21.4 Million
Q1 2021

May 07, 2021

BUY
$439.85 - $518.83 $1.63 Million - $1.93 Million
3,712 Added 9.03%
44,816 $20.5 Million
Q4 2020

Feb 04, 2021

BUY
$435.06 - $527.66 $1.52 Million - $1.84 Million
3,494 Added 9.29%
41,104 $19.1 Million
Q3 2020

Oct 29, 2020

BUY
$359.77 - $441.52 $740,046 - $908,206
2,057 Added 5.79%
37,610 $16.6 Million
Q2 2020

Jul 27, 2020

BUY
$275.2 - $362.34 $298,867 - $393,501
1,086 Added 3.15%
35,553 $12.9 Million
Q1 2020

May 08, 2020

BUY
$255.3 - $340.05 $2.74 Million - $3.65 Million
10,747 Added 45.31%
34,467 $9.77 Million
Q4 2019

Feb 04, 2020

BUY
$271.93 - $328.04 $87,289 - $105,300
321 Added 1.37%
23,720 $7.71 Million
Q3 2019

Nov 06, 2019

SELL
$268.46 - $305.43 $303,896 - $345,746
-1,132 Reduced 4.61%
23,399 $6.82 Million
Q3 2019

Oct 28, 2019

BUY
$268.46 - $305.43 $9,127 - $10,384
34 Added 0.14%
24,531 $7.15 Million
Q2 2019

Aug 15, 2019

BUY
$257.51 - $295.55 $376,222 - $431,798
1,461 Added 6.34%
24,497 $0
Q1 2019

May 08, 2019

BUY
$212.17 - $273.72 $1.21 Million - $1.56 Million
5,698 Added 32.86%
23,036 $0
Q4 2018

Feb 05, 2019

SELL
$208.47 - $251.98 $175,948 - $212,671
-844 Reduced 4.64%
17,338 $3.88 Million
Q3 2018

Nov 02, 2018

BUY
$205.57 - $244.32 $223,865 - $266,064
1,089 Added 6.37%
18,182 $0
Q2 2018

Aug 10, 2018

BUY
$203.14 - $219.53 $364,839 - $394,275
1,796 Added 11.74%
17,093 $0
Q1 2018

May 09, 2018

BUY
$192.98 - $224.11 $572,571 - $664,934
2,967 Added 24.06%
15,297 $0
Q4 2017

Feb 22, 2018

BUY
$182.03 - $200.37 $316,186 - $348,042
1,737 Added 16.4%
12,330 $0
Q3 2017

Nov 07, 2017

SELL
$171.74 - $194.04 $353,956 - $399,916
-2,061 Reduced 16.29%
10,593 $2 Million
Q2 2017

Aug 08, 2017

BUY
N/A
12,654
12,654 $2.21 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.